The impact of renal extracorporeal shock-wave lithotripsy on the use of resources in the Quebec health care system - nonsystematic review

Levy A, McGregor M
Record ID 31996008361
English, French
Authors' objectives:

To assess the effects of the introduction of extracorporeal shock-wave lithotripsy (ESWL) on the utilization of health care resources (coasts and bed-days) in Quebec.

Authors' results and conclusions: The introduction of ESWL has been associated with a marked reduction in the cost per renal stone patient treated. However, it has not resulted in a reduction of total costs to the Quebec health care system. The main reason why no cost reduction has been realized is that there has been a concomitant, major increase in age-standardized intervention rates (33% for males and 53% for females) and an approximately 59% increase in the number of individuals treated. It is unknown whether this increased rate represents an appropriate new level of intervention due to the availability of a new non-invasive procedure or the treatment of some individuals harbouring asymptomatic stones that would have never become symptomatic. From the point of view of Quebec hospitals, between 1984 and 1992, there has been a shift in bed utilization related to the treatment of urinary calculi from the 65 hospitals without a lithotripter (-7,518 bed-days) to the three hospitals possessing a lithotripter (+1,528 bed-days).
Authors' recomendations: It is suggested that the appropriateness of the additional number of interventions observed in recent years be reviewed by relevant health professionals. It is also important that the shift in resource utilization from one group of hospital to another be recognized by hospital and health care authorities when hospital budgets are reviewed.
Details
Project Status: Completed
Year Published: 1994
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Canada
MeSH Terms
  • Costs and Cost Analysis
  • Kidney Calculi
  • Lithotripsy
Contact
Organisation Name: Conseil d'Evaluation des Technologies de la Santé du Québec
Contact Address: Conseil d'Evaluation des Technologies de la Santé du Québec, 2021, avenue Union, #1040, Montréal, Québec H3A S29, Canada. Tel: 514-873-2563; FAX: 514-873-1369
Contact Name: aetmis@aetmis.gouv.qc.ca
Contact Email: aetmis@aetmis.gouv.qc.ca
Copyright: Conseil d'Evaluation des Technologies de la Sante du Quebec (CETS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.